Rs 200/Share Dividend Declared: MNC Pharma Stock Declares 6% Dip In PAT

Mid cap MNC pharmaceuticals sector company Procter & Gamble Health Ltd declared its financial results and interim dividend. Last trading price of Procter & Gamble Health shares on BSE is Rs 5319.40 apiece with intraday gain of 3.52%. Procter & Gamble Health shares witnessed a rally of over 7% year-to-date (YTD). Procter & Gamble Health declared an interim dividend of Rs 200 per equity shares having face value of Rs 10/- each. Dividend is expected to paid on or before March 3, 2024. Check details below:

Procter & Gamble Health Declares Interim Dividend: As per the exchange filing of the company dated February 6, 2024, "we are pleased to inform you that the Board of Directors of the Company at its meeting held today, inter alia, have declared an Interim Dividend for the Financial Year 2023-24 of Rs 200 (including one-time special dividend of Rs. 150) per Equity Share having face value of Rs. 10/- each. The dividend shall be paid on or before March 3, 2024."

Procter & Gamble Health Results: As per the BSE filing of Procter & Gamble Health dated February 6, 2024, "Procter & Gamble Health Limited (PGHL) announced today its financial results for the quarter ended December 31, 2023. In a challenging operating environment, the company reported sales of Rs 304 crores, at par vs a year ago. The Profit After Tax (PAT) for the quarter was Rs 72 crores, down 6% vs year ago, owing to one-time items in the quarter. Excluding this one-time impact, Profit After Tax (PAT) was up by 2% vs a year ago.

Mr. Milind Thatte, Managing Director, P&G Health India, said, "This has been a challenging quarter for the Company on account of an overall slowdown in the Vitamins, Minerals and Supplements category coupled with a delayed seasonal onset. The team continued to stay resilient. With improved productivity, efficiency and continued strategic investments, we have been able to deliver a modest topline and bottom-line."

We remain committed to our integrated growth strategy of a focused product portfolio, superiority, productivity, constructive disruption, and an agile and accountable organization structure. We are confident that this strategy combined with our operational agility will help us navigate the mid-term and deliver balanced growth, added Milind Thatte.

Procter & Gamble Health Shares Performance & Return: The 52-week high price of Procter & Gamble Health shares on BSE is Rs 5496.50 per share and 52-week low price is Rs 4287.05 apiece, respectively. The company has a market capitalisation of Rs 8829.88 crore. Procter & Gamble Health shares gained 3% in last 1-week, jumped 13% in last 1-year, and offered return of 5% in last 2-years. In last 3-years, Procter & Gamble Health shares declined 26% and rallied 62% in last 5-years.

About: Procter & Gamble Health Limited is one of India's largest VMS companies manufacturing and marketing vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion.

Disclaimer:

The stock just dividend, results and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.